Literature DB >> 7092339

Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus.

C P Maury, A M Teppo, O Wegelius.   

Abstract

The urinary excretion of sialic-acid-containing oligosaccharides, total sialic acid, serum amyloid A protein (SAA), and C-reactive protein (CRP) has been studied in 48 patients with rheumatoid arthritis (RA) and in 17 patients with systemic lupus erythematosus (SLE). Linear regression analysis revealed a close positive correlation between serum SAA and CRP levels in both RA (r = 0.71, p less than 0.001) and SLE (r = 0.86, p less than 0.001). The urinary excretion of sialyl lactose showed a positive correlation with the serum levels of SAA and CRP in RA (r = 0.45 and r = 0.45, respectively, p less than 0.01) but not in SLE (r = 0.05 and r = 0.10 respectively). Changes in serum total sialic acid levels paralleled those in CRP and SAA in RA as well as in SLE. Patients with very active RA had higher urinary sialyl oligosaccharide excretion (p less than 0.001), higher CRP levels (p less than 0.01), and higher SAA levels ( p less than 0.05) than those with moderately active disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092339      PMCID: PMC1000925          DOI: 10.1136/ard.41.3.268

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Interactions of C-reactive protein with the first component of human complement.

Authors:  D R Claus; J Siegel; K Petras; A P Osmand; H Gewurz
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  C-reactive protein in systemic lupus erythematosus.

Authors:  S Honig; P Gorevic; G Weissmann
Journal:  Arthritis Rheum       Date:  1977-06

3.  Increased urinary excretion of neuraminic acid-containing oligosaccharides after myocardial infarction.

Authors:  J K Huttunen; P Maury; T A Miettinen
Journal:  J Mol Cell Cardiol       Date:  1972-02       Impact factor: 5.000

4.  Effects of age, sex, fasting and surgery on the excretion of neuraminyllactose and neuraminyl-N-acetyllactosamine in rat urine.

Authors:  P Maury; J K Huttunsen
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

5.  Quantitative determination of urinary neuraminyl oligosaccharides by gas-liquid chromatography.

Authors:  J K Huttunen; T A Miettinen
Journal:  Anal Biochem       Date:  1969-06       Impact factor: 3.365

6.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

7.  Excretion of neuraminic acid-containing trisaccharides in the urine during pregnancy.

Authors:  P Maury
Journal:  Clin Chim Acta       Date:  1976-09-06       Impact factor: 3.786

8.  Dynamics of glomerular ultrafiltration in the rat. V. Response to ischemic injury.

Authors:  T M Daugharty; I F Ueki; P F Mercer; B M Brenner
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

9.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

10.  Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.

Authors:  M Levin; M Pras; E C Franklin
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  11 in total

1.  Urine oligosaccharide pattern in patients with hyperprolactinaemia.

Authors:  Bertil Ekman; Jeanette Wahlberg; Eva Landberg
Journal:  Glycoconj J       Date:  2015-08-15       Impact factor: 2.916

Review 2.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

3.  Antibodies to amyloid A protein in rheumatic diseases.

Authors:  C P Maury; A M Teppo
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  Serum amyloid A protein in acute viral infections.

Authors:  H Miwata; T Yamada; M Okada; T Kudo; H Kimura; T Morishima
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease.

Authors:  J G Raynes; E H Cooper
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

6.  Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.

Authors:  Jose A Gómez-Puerta; Ricard Cervera; Concepción Moll; Manel Solé; Antonio Collado; Raimon Sanmartí
Journal:  Clin Rheumatol       Date:  2008-10-22       Impact factor: 2.980

7.  Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.

Authors:  C P Maury; T Helve; C Sjöblom
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

8.  CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells.

Authors:  Irina N Baranova; Alexander V Bocharov; Tatyana G Vishnyakova; Roger Kurlander; Zhigang Chen; Dong Fu; Irwin M Arias; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

9.  Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis.

Authors:  H M Falck; C P Maury; A M Teppo; O Wegelius
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

Review 10.  Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Ghislain Opdenakker; Sofie Struyf; Jo Van Damme
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.